42 related articles for article (PubMed ID: 27394702)
1. Preface to the Special issue: Diagnosis and treatment of acromegaly, a paradigmatic disease.
Mercado M
Best Pract Res Clin Endocrinol Metab; 2024 May; 38(3):101897. PubMed ID: 38677954
[No Abstract] [Full Text] [Related]
2. Acromegaly: a clinical perspective.
Lawrence L; Alkwatli K; Bena J; Prayson R; Kshettry V; Recinos P; Hatipoglu B; Pantalone KM; Weil R; Hamrahian AH; Kennedy L; Yogi-Morren D
Clin Diabetes Endocrinol; 2020; 6():15. PubMed ID: 32843993
[TBL] [Abstract][Full Text] [Related]
3. STEREOTACTIC RADIATION THERAPY IN PITUITARY ADENOMAS, IS IT BETTER THAN CONVENTIONAL RADIATION THERAPY?
Gheorghiu ML; Fleseriu M
Acta Endocrinol (Buchar); 2017; 13(4):476-490. PubMed ID: 31149219
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness and safety of pegvisomant: a systematic review and meta-analysis of observational longitudinal studies.
Leonart LP; Tonin FS; Ferreira VL; Fernandez-Llimos F; Pontarolo R
Endocrine; 2019 Jan; 63(1):18-26. PubMed ID: 30145746
[TBL] [Abstract][Full Text] [Related]
5. Updates in outcomes of stereotactic radiation therapy in acromegaly.
Gheorghiu ML
Pituitary; 2017 Feb; 20(1):154-168. PubMed ID: 28210908
[TBL] [Abstract][Full Text] [Related]
6. Beneficial effect of dose escalation and surgical debulking in patients with acromegaly treated with somatostatin analogs in a Romanian tertiary care center.
Gheorghiu ML; Găloiu S; Vintilă M; Purice M; Hortopan D; Dumitraşcu A; Coculescu M; Poiană C
Hormones (Athens); 2016 Apr; 15(2):224-234. PubMed ID: 27376425
[TBL] [Abstract][Full Text] [Related]
7. Acromegaly.
Scacchi M; Cavagnini F
Pituitary; 2006; 9(4):297-303. PubMed ID: 17077948
[TBL] [Abstract][Full Text] [Related]
8. Paradoxical GH Increase During OGTT Is Associated With First-Generation Somatostatin Analog Responsiveness in Acromegaly.
Scaroni C; Albiger N; Daniele A; Dassie F; Romualdi C; Vazza G; Regazzo D; Ferraù F; Barresi V; Maffeis V; Gardiman MP; Cannavò S; Maffei P; Ceccato F; Losa M; Occhi G
J Clin Endocrinol Metab; 2019 Mar; 104(3):856-862. PubMed ID: 30285115
[TBL] [Abstract][Full Text] [Related]
9. Normalisation of plasma growth hormone levels improved cardiac dysfunction due to acromegalic cardiomyopathy with severe fibrosis.
Yokota F; Arima H; Hirano M; Uchikawa T; Inden Y; Nagatani T; Oiso Y
BMJ Case Rep; 2010 Sep; 2010():. PubMed ID: 22791498
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic trends and outcome of acromegaly: a single center experience over a 40-year period.
Karapanou O; Tzanela M; Christoforaki M; Papastathopoulou L; Moutsatsou P; Botoula E; Tsagarakis S
Hormones (Athens); 2016 Jul; 15(3):368-376. PubMed ID: 27394702
[TBL] [Abstract][Full Text] [Related]
11. Neuroendocrine tumors secreting growth hormone-releasing hormone: Pathophysiological and clinical aspects.
Gola M; Doga M; Bonadonna S; Mazziotti G; Vescovi PP; Giustina A
Pituitary; 2006; 9(3):221-9. PubMed ID: 17036195
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
